Watch, Listen and Learn: CARB-X

The Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, or CARB-X, was created to help address the threat of antibiotic resistance.CDC estimates that drug-resistant bacterial infections affect 2 million people and kill 23,000 people in the U.S. each year. CARB-X may be the largest public-private partnership for pre-clinical antibiotic development. Find out why it matters and how it works. Learn More >>